• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 453231 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414063897 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414063897 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Hot Stock: EnteroMedics, Shares Gain 7.2% (ETRM)

Published on Tue, 03/05/2013 - 13:23
By Adrienne Chilton

EnteroMedics (NASDAQ:ETRM) is one of today's best performing penny stocks, up 7.2% to $0.95 on 1.1x average daily volume. Thus far today, EnteroMedics has traded 1.6 million shares, vs. average volume of 1.4 million shares per day. The stock has outperformed the Dow (7.2% to the Dow's 1.0%) and outperformed the S&P 500 (7.2% to the S&P's 1.0%) during today's trading.

EnteroMedics has overhead space with shares priced $0.95, or 76.9% below the average consensus analyst price target of $4.12. The stock should find initial resistance at its 50-day moving average (MA) of $2.15 and further resistance at its 200-day MA of $3.04.

In the past 52 weeks, EnteroMedics share prices have been bracketed by a low of $0.81 and a high of $4.40 and are now at $0.95, 18% above that low price. The 200-day and 50-day moving averages have moved 0.95% lower and 3.99% lower over the past week, respectively.

EnteroMedics Inc. is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Tesoro: 52-Week High Recently Eclipsed (...

Tesoro (NYSE:TSO) traded at a new 52-week high today of $68.26. This new high was reac ...

Travelers Looks to Continue to Trade Abo...

Shares of Travelers (NYSE:TRV) traded at a new 52-week high today of $96.29. This new ...

Shares of TECO Energy Rise Above Previou...

TECO Energy (NYSE:TE) traded at a new 52-week high today of $19.25. Approximately 2.3 ...

Recent 52-Week High Exceeded in Shares o...

STERIS (NYSE:STE) traded at a new 52-week high today of $58.58. So far today approxima ...

Sovran Self Storage: The Winning Streak ...

Sovran Self Storage (NYSE:SSS) traded at a new 52-week high today of $82.00. So far to ...

Sonic: 52-Week High Recently Eclipsed (S...

Sonic (NASDAQ:SONC) traded at a new 52-week high today of $24.89. Approximately 1.2 mi ...

Snap-On Looks to Continue to Trade Above...

Snap-On (NYSE:SNA) traded at a new 52-week high today of $128.65. Approximately 354,00 ...

Super Micro Computer: The Winning Streak...

Shares of Super Micro Computer (NASDAQ:SMCI) traded at a new 52-week high today of $30. ...